Sun Pharma Advanced Research Company Ltd (SPARC) — Announcement | 25 September 2026
Sun Pharma Advanced Research Company Ltd (SPARC) has announced that its trading window will close on October 1, 2026, and remain shut for 48 hours after the unaudited Q2 results announcement, expected around September 30, 2026, to prevent insider trading during financial disclosure.
About Sun Pharma Advanced Research Company Ltd (SPARC)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when SPARC files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SPARC — Free💡 Ask AI about this filing
📊 More SPARC filings
- Announcement — 13 August 2026Sun Pharma Advanced Research Company Limited (SPARC) has formally submitted an application to stock ...
- 🟡 Board Meeting — 10 August 2026The board approved unaudited standalone and consolidated financial results for Q1 FY26 ending June 3...
- 🟡 deviation variation — 10 August 2026The Monitoring Agency Report confirms no deviation in the utilization of proceeds from SPARC's prefe...
- 🟡 Board Meeting — 10 August 2026SPARC held its 21st AGM on August 10, 2026, via video conference, where shareholders approved all re...
- 🔴 Annual Report — 6 July 2026Sun Pharma Advanced Research Company Limited announced its 21st Annual General Meeting will be held ...
🔥 Also filed on 25 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SPARC files new disclosures
Track SPARC filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SPARC — FreeFree account · 2 AI queries/day